Register your Account

Sign Up with us and Enjoy!
User name Email First Name Last Name Contact info

A password will be e-mailed to you.

Home » Medical

NASDAQ NYSE MOST ACTIVES: Alon Blue Square Israel Ltd, Cubist Pharmaceuticals Inc, Intrexon Corp, Vimicro International Corporation (ADR)

New York, NY – (MeshPress) — 12/08/2014 — PSPicks.com announces todays NASDAQ, NYSE most advanced stocks. PSPicks.com provides it’s members with a free newsletter that reports up to the minute information and exclusive charts on cheap,...  [...]

Read More  »

Today’s 3 Unpredictable Shares : Amarin Corporation plc (NASDAQ:AMRN), Teva Pharmaceutical Industries Ltd (NYSE:TEVA), Neuroderm Ltd. (NASDAQ:NDRM)

New York, NY – (MeshPress) — 11/28/2014 — Amarin Corporation plc (NASDAQ:AMRN) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101,...  [...]

Read More  »

Early Morning Health Concern : Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), Evoke Pharma, Inc. (NASDAQ:EVOK)

New York, NY – (MeshPress) — 11/28/2014 — Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety...  [...]

Read More  »

Eye-Popping Medical Stocks: ULURU Inc. (OTCMKTS:ULUR), MiMedx Group Inc (NASDAQ:MDXG), Anika Therapeutics, Inc. (NASDAQ:ANIK)

New York, NY – (MeshPress) — 11/25/2014 — ULURU Inc. (OTCMKTS:ULUR) announced its financial results for the third quarter ended September 30, 2014. For the third quarter of 2014, the Company reported a net loss of $679,000, or $0.03 per share,...  [...]

Read More  »

Notable Stocks Highlights : Nanosphere, Inc. (NASDAQ:NSPH), Genomic Health, Inc. (NASDAQ:GHDX), Myriad Genetics (NASDAQ:MYGN)

New York, NY – (MeshPress) — 11/24/2014 — Nanosphere, Inc. (NASDAQ:NSPH) develops, manufactures and markets a molecular diagnostics platform, the Verigene System. The Company’s nanoparticle technology provides the ability to run multiple tests...  [...]

Read More  »

Biotech News Pulse : Seattle Genetics, Inc. (NASDAQ:SGEN), AbbVie Inc (NYSE:ABBV), Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

New York, NY – (MeshPress) — 11/19/2014 — Seattle Genetics, Inc. (NASDAQ:SGEN) announced the company appointed Ms. Jean I. Liu, as General Counsel, Executive Vice President, Legal Affairs and Corporate Secretary. Ms. Liu replaces Kirk Schumacher,...  [...]

Read More  »

Big 3 Biotech Winners: Intuitive Surgical, Inc (NASDAQ:ISRG), Conmed Corp. (NASDAQ:CNMD), Misonix, Inc. (NASDAQ:MSON)

New York, NY – (MeshPress) — 11/18/2014 — Intuitive Surgical, Inc (NASDAQ:ISRG) declared that top 5 U.S. medical centers selected to get awarded for the increase of training opportunities in minimally invasive surgical techniques. Each of them...  [...]

Read More  »

Stocks with Hot Volumes : Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (ADR) (NYSE:GSK), Sanofi SA (ADR) (NYSE:SNY)

Los Angelas, CA – (MeshPress) — 11/06/2014 — Pfizer Inc. (NYSE:PFE) is a research-based, global biopharmaceutical company. The Company’s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and...  [...]

Read More  »

Latest Active Healthy Options: Johnson & Johnson (NYSE:JNJ), Medtronic Inc. (NYSE:MDT), Abbott Laboratories (NYSE:ABT)

Los Angelas, CA – (MeshPress) — 10/31/2014 — Johnson & Johnson (NYSE:JNJ) announced that it has agreed a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program in development at its...  [...]

Read More  »

Daily Upward Movers : Minerva Neurosciences, Inc. (NASDAQ:NERV), Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT), Titan Pharmaceuticals, Inc. (OTCBB:TTNP)

Los Angelas, CA – (MeshPress) — 10/30/2014 — Minerva Neurosciences, Inc. (NASDAQ:NERV) is a biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central...  [...]

Read More  »